Boston Scientific CEO Michael Mahoney's 2018 pay rises 7% to $14M

Boston Scientific reports 2018 executive compensation

By ExecPay News

Published: March 27, 2019

Boston Scientific reported fiscal year 2018 executive compensation information on March 27, 2019.
In 2018, five executives at Boston Scientific received on average a compensation package of $5.4M, a 3% decrease compared to previous year.
Average pay of disclosed executives at Boston Scientific
Michael F. Mahoney, Chief Executive Officer, received $14M in total, which increased by 7% compared to 2017. 55% of Mahoney's compensation, or $7.6M, was in stock awards. Mahoney also received $312K of change in pension value and nonqualified deferred compensation earnings, $2.1M in non-equity incentive plan, $2.5M in option awards, $1.2M in salary, as well as $152K in other compensation.
For fiscal year 2018, the median employee pay was $62,447 at Boston Scientific. Therefore, the ratio of Michael F. Mahoney's pay to the median employee pay was 224 to one.
Joseph M. Fitzgerald, Executive Vice President and President, Rhythm Management, received a compensation package of $4M, which decreased by 31% compared to previous year. 47% of the compensation package, or $1.9M, was in stock awards.
Daniel J. Brennan, Chief Financial Officer, earned $3.7M in 2018, a 1% increase compared to previous year.
Kevin J. Ballinger, Executive Vice President and President, Interventional Cardiology, received $2.8M in 2018, which increases by 1% compared to 2017.
David A. Pierce, Executive Vice President and President, MedSurg, earned $2.7M in 2018.

Related executives

Michael Mahoney

Boston Scientific

Chief Executive Officer

Daniel Brennan

Boston Scientific

Chief Financial Officer

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

Joseph Fitzgerald

Boston Scientific

Executive Vice President and Group President, Cardiology

David Pierce

Boston Scientific

Executive Vice President and President, MedSurg

You may also like

Source: SEC filing on March 27, 2019.